Six-month field efficacy and safety of the combined treatment of dogs with Frontline Tri-Act® and NexGard Spectra®

Six-month field efficacy and safety of the combined treatment of dogs with Frontline Tri-Act® and NexGard Spectra®

Abstract Background Safety and efficacy of the combined monthly use of spot-on fipronil 6.76% w/v / permethrin 50.48% w/v (Frontline Tri-Act®) and chewable tablets of afoxolaner 1.9% w/w / milbemycin oxime 0.4% w/w (NexGard Spectra®) in dogs was evaluated in a field study over a period of 6 months....

Full description

Bibliographic Details
Main Authors: Jessica M. Abbate, Ettore Napoli, Francesca Arfuso, Gabriella Gaglio, Salvatore Giannetto, Lenaig Halos, Frederic Beugnet, Emanuele Brianti
Format: Article
Language:English
Published: BMC 2018-07-01
Series:Parasites & Vectors
Subjects:
Afoxolaner/milbemycin oxime
Canine vector-borne diseases
Ectoparasites
Efficacy
Fipronil/permethrin
Nematodes
Online Access:http://link.springer.com/article/10.1186/s13071-018-2957-7

Internet

http://link.springer.com/article/10.1186/s13071-018-2957-7

Similar Items